Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Mach7 Technologies ( (AU:M7T) ).
Mach7 Technologies has announced a change in its registered office and principal place of business to a new address in Melbourne, Australia. This move is part of the company’s ongoing operations, with no other changes to its contact details or business operations, indicating stability and continuity for stakeholders.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is a medical imaging technology provider that specializes in innovative data management and image viewing solutions for healthcare organizations. Its primary product, the Mach7 Enterprise Imaging Solution, includes a Vendor Neutral Archive, eUnity Enterprise Diagnostic Viewer, and Diagnostic Workflow Applications, offering flexibility and scalability to a global network of healthcare providers.
YTD Price Performance: -7.50%
Average Trading Volume: 250,077
Technical Sentiment Signal: Sell
Current Market Cap: A$89.26M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue